ABSTRACT
The ability of the host-immune defense mechanism of nude mice and their immunocompetent littermates to prevent liver metastases from the murine colon carcinoma, colon-26, was assessed. Give thousand tumor cells suspended in 0.05 ml of Hank's balanced salt solution were inoculated into the spleens of BALB/c nu/+ and BALB/c nu/nu mice. On the 21st day after inoculation, all the mice were sacrificed, and the liver metastases counted and the livers weighed. All the BALB/c nu/+ mice were found to have developed hepatic metastases with a mean of 10 nodules, whereas no hepatic metastases were observed in any of the 10 BALB/c nude mice. On the other hand, 4 of 6 nude mice developed hepatic metastases after treatment with anti-asialo GM1 antibody. These results indicate that the BALB/c nude mouse has an excellent host-immune defense mechanism for preventing liver metastasis, with NK cells in the liver and/or blood circulation perhaps playing an important role.
Subject(s)
Colonic Neoplasms/surgery , G(M1) Ganglioside , Liver Neoplasms/prevention & control , Mice, Inbred BALB C/immunology , Mice, Nude/immunology , Animals , Antibodies/administration & dosage , Evaluation Studies as Topic , Glycosphingolipids/immunology , Immunity, Innate , Killer Cells, Natural/analysis , Liver Neoplasms/immunology , Liver Neoplasms/secondary , Male , Mice , Time Factors , Transplantation, HomologousABSTRACT
Murine natural killer (NK) cell-mediated inhibition of growth of a yeast-like target cell, Cryptococcus neoformans, was completely abrogated by blocking the effector cell secretory process with monensin. Therefore, further studies were performed to determine the ability of various cytoplasmic fractions of NK cells to mediate inhibition of cryptococcal growth. Percoll-fractionated homogenates of rat LGL tumor cells demonstrated that the granule-containing fractions plus three additional sets of less dense cytoplasmic fractions displayed anti-cryptococcal activity; whereas only the cytoplasmic granule-containing fractions had cytotoxic activity against YAC-1 tumor cell and sheep erythrocyte targets. Maximal cryptococcal growth inhibition induced by LGL granules occurred after a 1 h incubation, required the presence of Ca2+ (1.0 mM) or Mg2+ (0.5 mM or 5.0 mM), and was completely abrogated in the presence of rabbit anti-LGL granule IgG. Cytolysin, the granule component which mediates tumor cell and sheep erythrocyte lysis, effectively limited the growth of cryptococci. Since Percoll gradient fractionation of the LGL homogenates demonstrated three separate peaks of anti-cryptococcal activity other than the granule peak, it is possible that the cytolysin-containing granules are not the only subcellular component of NK cells playing a role in inhibition of C. neoformans growth.
Subject(s)
Cryptococcus neoformans/growth & development , Cryptococcus/growth & development , Cytoplasm/microbiology , Cytoplasmic Granules/physiology , Cytotoxins/physiology , Killer Cells, Natural/ultrastructure , Animals , Calcium/pharmacokinetics , Colony Count, Microbial , Cryptococcus neoformans/drug effects , Cytoplasm/analysis , Cytoplasmic Granules/analysis , Cytoplasmic Granules/immunology , Cytotoxins/analysis , Immunoglobulin G/analysis , Immunoglobulin G/immunology , Killer Cells, Natural/analysis , Killer Cells, Natural/physiology , Lymphoma/immunology , Lymphoma/pathology , Lymphoma/physiopathology , Mice , Monensin/pharmacology , Rats , Rats, Inbred F344 , Splenic Neoplasms/immunology , Splenic Neoplasms/pathology , Splenic Neoplasms/physiopathology , Tumor Cells, Cultured/immunology , Tumor Cells, Cultured/pathology , Tumor Cells, Cultured/physiologyABSTRACT
The activation of large granular lymphocytes (LGLs)/natural killer (NK) cells with interleukin-2 (IL-2) has been shown to increase the ability of these cells to lyse NK-resistant tumor target cells. Activated LGLs, termed LAK (lymphokine-activated killer) cells, have been demonstrated to be of therapeutic value in vivo against metastatic tumors. The mechanism by which IL-2 induces broadened cytolytic capability, as well as the molecular basis of target recognition and killing by the activated cells has not yet been elucidated. Since carbohydrate moieties have been demonstrated to be of possible significance in the cytolytic cascade of a variety of effector cells, the current study was undertaken to determine if the activation of LGLs with IL-2 is accompanied by an alteration of cell-surface carbohydrates. Two-color flow cytometry was performed to identify LGL/NK cells in populations of nylon wool-nonadherent splenic mononuclear cells and to assess the binding of various lectins to activated as well as nonactivated LGLs. Increases were observed in the binding of four lectins to LGLs after IL-2 activation; Triticum vulgaris (wheat germ agglutinin), Phytolacca americana (pokeweed mitogen), Lycopersicon esculentum (tomato lectin), and Griffonia simplicifolia I-B4 (GSI-B4). The wheat germ, pokeweed, and tomato lectins recognize complex carbohydrates structure consisting of GlcNAc(Bl,4GlcNAc)n while GSI-B4 recognizes alpha-D-galactose terminal end groups. Lectin binding to the activated LGLs was homogenous (i.e., flow cytometry revealed only a single population of fluorescent cells). Lectin binding to LGLs prior to activation was more heterogeneous, however, the tomato lectin uniquely revealed a bimodal distribution of receptors. These data indicate that LGL/NK cells from the rat are heterogeneous in their ability to bind specific lectins, and that IL-2 activation of these cells results in altered expression of specific cell-surface carbohydrates.
Subject(s)
Glycoconjugates/analysis , Interleukin-2/pharmacology , Killer Cells, Lymphokine-Activated/immunology , Killer Cells, Natural/immunology , Lymphocyte Activation , Animals , Flow Cytometry , Killer Cells, Lymphokine-Activated/analysis , Killer Cells, Natural/analysis , Rats , Rats, Inbred F344 , Receptors, Mitogen/analysisABSTRACT
FcRIII is not present on peripheral blood monocytes, but becomes expressed upon culturing and can be demonstrated on tissue macrophages. We studied the expression of FcRIII of cultured monocytes in detail and compared its structure with FcRIII of neutrophils and NK cells. The cell density of FcRIII reached a plateau within 3 days of culturing. During that time, the expression of FcRI and FcRIIa, also present on monocytes, did not change significantly. FcRIII on cultured monocytes lacked, as did NK cell FcRIII, the NA1-allotypic variant of the NA system present on the neutrophil FcRIII. Studies with glycosyl-phosphatidyl-inositol-specific phospholipase C and analysis of cells of patients with paroxysmal nocturnal hemoglobinuria revealed that FcRIII on cultured monocytes is not anchored by phosphatidyl-inositol-glycan in the cell membrane. Similarly, FcRIII on NK cells was resistant to glycosyl-phosphatidyl-inositol-specific phospholipase C treatment, suggesting that NK cell FcRIII is also not anchored by a phosphatidyl-inositol-glycan moiety, in contrast to neutrophil FcRIII. Analysis by SDS-PAGE showed that the FcRIII of cultured monocytes had a similar mobility as the FcRIII on NK cells, but was clearly distinct from neutrophil FcRIII. Treatment with N-glycanase showed that the protein backbone of deglycosylated FcRIII of cultured monocytes was similar to that of FcRIII of NK cells, but deglycosylated neutrophil FcRIII was different. Specific blocking of FcRIII of cultured monocytes with an anti-FcRIII mAb did not reduced the lytic action of the cultured monocytes towards sensitized erythrocytes. However, FcRIII was modulated from the cell surface by incubation with sensitized E, whereas non-FcR Ag were not. These findings indicate that FcRIII is involved in binding of immune complexes, but does not act as a trigger molecule for extracellular lysis of sensitized E.
Subject(s)
Antibody-Dependent Cell Cytotoxicity , Antigens, Differentiation/physiology , Monocytes/immunology , Receptors, Fc/physiology , Amidohydrolases/pharmacology , Antigens, Differentiation/analysis , Cells, Cultured , Erythrocytes/immunology , Glycolipids/metabolism , Glycosylphosphatidylinositols , Humans , In Vitro Techniques , Killer Cells, Natural/analysis , Molecular Weight , Monocytes/analysis , Neutrophils/analysis , Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase , Phosphatidylinositols/metabolism , Precipitin Tests , Receptors, Fc/analysis , Receptors, IgGABSTRACT
In this report, we describe the transcription of messenger ribonucleic acid (mRNA) specific for the core protein of chondroitin sulfate proteoglycan (CSPG), the entire sequence of the message for CSPG core protein and the presence of CSPG in the granules of a highly purified population of recombinant interleukin-2 (rIL-2)-stimulated rat natural killer (NK), i.e. adherent lymphokine-activated Killer (A-LAK), cells. The presence of CSPG in A-LAK cell granules was demonstrated by a variety of biochemical and immunologic methods. Further, we have demonstrated the presence of a 1.1-kilobase (kb) transcript for the core protein of CSPG by Northern blot analysis using a specific probe (pPG6) derived from a rat yolk sac tumor cell line (L-2). Three cell types that contained CSPG in granules produced a transcript of 1.1 kb, whereas L-2 cells, which localize CSPG on the cell surface, produced a transcript of 1.3 kb. A complementary DNA (cDNA) library was prepared from rat A-LAK cells and the gene for the CSPG core protein was cloned. From approximately 1.2 X 10(5) recombinant phages, 5 positive clones were obtained. The longest clone, PG-NK-5, was sequenced in its entirety and it was found to encode the entire sequence of the CSPG core protein. The other 4 clones were partially sequenced and were identical to PG-NK-5. Comparison of the sequence of PG-NK-5 with pPG6 indicated that they were nearly identical. However, all NK-cell-derived cDNAs contained a poly(A) tail that started 20 basepairs upstream from other published sequences for CSPG core proteins. These data represent the first description of the sequence of the core protein of CSPG contained in NK cells.
Subject(s)
DNA/isolation & purification , Extracellular Matrix Proteins , Glycoproteins/genetics , Killer Cells, Natural/analysis , Proteoglycans , Aggrecans , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cell Line , Cloning, Molecular , Cytoplasmic Granules/analysis , Cytoplasmic Granules/physiology , DNA/genetics , Glycoproteins/analysis , Interleukin-2/pharmacology , Killer Cells, Lymphokine-Activated/analysis , Lectins, C-Type , Molecular Sequence Data , RNA, Messenger/genetics , Rats , Rats, Inbred F344 , Recombinant ProteinsABSTRACT
The utility of CD4 lymphocytes in monitoring disease progression and prognosis of human immunodeficiency virus (HIV)-infected patients is well established. We have modified a previously described antibody cocktail to provide complete lymphocyte subset analysis on 100-200-microL samples of whole blood. This method optimizes accuracy of CD4 lymphocyte assessments and provides simultaneous assessment of four other lymphocyte subtypes of interest in specimens with absolute lymphocyte counts as low as 300 X 10(6)/L. Lymphocytes are classified as Thelper (CD3+CD4+); Tsuppressor (CD3+CD8+); Tnull (CD3+CD4-CD8-, putative gamma delta T-cell receptor); B (CD19+CD20+); or natural killer (CD3-CD16+CD56+). The method positively discriminates against contamination of lymphocyte scatter gates by monocytes and unlysed erythrocytes and is compatible with a variety of cell preparation procedures. Increased accuracy of CD4 lymphocyte determinations and simultaneous identification of other lymphocyte subsets whose relationship to disease progression is under study make this an efficient and informative method for disease monitoring and evaluation of therapy in HIV-infected patients.
Subject(s)
Flow Cytometry , HIV Infections/immunology , Lymphocytes/analysis , Antibodies, Monoclonal , B-Lymphocytes/analysis , Blood Specimen Collection , Cell Separation , Humans , Killer Cells, Natural/analysis , Leukocyte Count/methods , Lymphocytes, Null/analysis , Single-Blind Method , T-Lymphocytes, Helper-Inducer/analysis , T-Lymphocytes, Regulatory/analysis , Time FactorsABSTRACT
Natural killer cell activity was assessed in 100 previously untreated pharyngeal carcinoma patients. Diminished natural killer cell function in these patients was associated with an increased risk of death from uncontrolled regional and distant metastases. During the assessment, the cell line MDA686-Ln was established from a metastatic pharyngeal carcinoma of a patient with low natural killer cell cytotoxicity. The initially cytotoxicity-resistant cell line could be lysed when natural killer cell cytotoxicity was enhanced in vitro either through enrichment of a Leu 19+ natural killer cell population by fluorescent-activated cell sorting or by interleukin-2 activation. Additionally, increased circulating immune complexes were identified in these patients, subsequently isolated, and found to block natural killer cell reactivity against MDA686-Ln. In light of this negative interaction, 38 patients were randomly evaluated for both circulating immune complex levels and natural killer cell function. Both parameters examined together were complementary in defining the risk of death with disease; four of five deaths occurred in patients with both high circulating immune complex levels and low natural killer cell function. Results support the biologic modification of natural killer cell activity for controlling metastatic pharyngeal carcinoma and point to the potential confounding influence of circulating immune complex.
Subject(s)
Antigen-Antibody Complex/immunology , Carcinoma, Squamous Cell/immunology , Killer Cells, Natural/immunology , Neoplasm Metastasis/immunology , Pharyngeal Neoplasms/immunology , Adult , Aged , Aged, 80 and over , Antigen-Antibody Complex/analysis , Carcinoma, Squamous Cell/pathology , Female , Humans , Interleukin-2/immunology , Killer Cells, Natural/analysis , Male , Middle Aged , Neoplasm Staging , Palatal Neoplasms/immunology , Palatal Neoplasms/pathology , Palate, Soft , Pharyngeal Neoplasms/pathology , Tongue Neoplasms/immunology , Tongue Neoplasms/pathology , Tonsillar Neoplasms/immunology , Tonsillar Neoplasms/pathology , Tumor Cells, CulturedABSTRACT
CTL and NK cells produce a cytolytic pore-forming protein (perforin, cytolysin) localized in their cytoplasmic granules. These cytotoxic cells are resistant to killing mediated by other lymphocytes and by purified perforin. A membrane factor, known as homologous restriction factor (HRF), has been suggested to confer protection to different cell types against both C- and perforin-mediated lysis. The granules of human large granular lymphocytes have been reported to contain, in addition to perforin, a soluble HRF activity that can be eluted from anion-exchange columns at 115 mM NaCl. Here, we report that a soluble HRF activity is absent in the granules or the cytosol of murine CTL and human NK cells. Our data indicate that the inhibition attributed to HRF could be explained by exogenous EDTA added during granule fractionation. EDTA was shown to bind to Mono Q and to elute at 90 to 120 mM NaCl. A second perforin-inhibitory activity was also eluted from such a column. However, it was present in preparations obtained not only from CTL and NK cells, but also from some perforin-susceptible tumor cell lines, indicating that it has nonrestricted distribution and suggesting that it is probably irrelevant to the perforin-protection mechanism. Our results argue against a role for soluble granule HRF or other soluble factors in mediating resistance of cytotoxic lymphocytes against perforin-mediated lysis.
Subject(s)
Blood Proteins/physiology , CD59 Antigens , Carrier Proteins , Cytotoxicity, Immunologic , Killer Cells, Natural/immunology , Membrane Glycoproteins , Membrane Proteins/physiology , T-Lymphocytes, Cytotoxic/immunology , Animals , Binding, Competitive , Calcium/pharmacology , Cell Fractionation , Cell Line , Complement System Proteins/physiology , Edetic Acid/pharmacology , Hemolysis , Hot Temperature , Humans , Immunity, Innate , Killer Cells, Natural/analysis , Membrane Proteins/antagonists & inhibitors , Mice , Papain , Perforin , Pore Forming Cytotoxic Proteins , Solubility , T-Lymphocytes, Cytotoxic/analysis , TrypsinSubject(s)
Membrane Glycoproteins , Membrane Proteins/physiology , Animals , Complement System Proteins , Cytotoxicity, Immunologic , Hydrogen-Ion Concentration , Killer Cells, Natural/analysis , Killer Cells, Natural/immunology , Membrane Proteins/isolation & purification , Molecular Structure , Perforin , Pore Forming Cytotoxic Proteins , T-Lymphocytes/analysis , T-Lymphocytes/immunologyABSTRACT
In peripheral blood most NK activity is mediated by CD3- cells with large granular lymphocyte morphology which cannot be assigned to a specific hemopoietic lineage. In accordance with previous studies we have analyzed the organization of the TCR delta gene, which rearranges early in thymic ontogeny, in normal NK cells, and in granular lymphocytes proliferative disorders (GLPD), in an effort to further define their relationship to the T cell differentiation pathway and to identify a possible marker of clonality for CD3- GLPD. The alpha/delta locus was rearranged in five cases of CD3+ GLPD with a biallelic deletion of the C delta region, suggesting V-J alpha rearrangement, whereas CD3- GLPD and normal CD3- NK cells had the delta gene in germ-line configuration, but surprisingly expressed high levels of TCR delta-related mRNA. On the basis of this finding and of the presence of truncated TCR-beta and CD3-epsilon mRNA, we are led to speculate on a possible ontogenic relationship of NK cells to the T cell differentiation pathway at stages preceding TCR gene rearrangement.
Subject(s)
Gene Rearrangement, T-Lymphocyte , Killer Cells, Natural/metabolism , Leukemia, T-Cell/genetics , Lymphoproliferative Disorders/genetics , Receptors, Antigen, T-Cell/genetics , Antigens, Differentiation, T-Lymphocyte/genetics , CD3 Complex , Cytotoxicity, Immunologic , DNA Probes , Humans , Killer Cells, Natural/analysis , Leukemia, T-Cell/immunology , Lymphoproliferative Disorders/immunology , Phenotype , RNA, Messenger/isolation & purification , Receptors, Antigen, T-Cell, gamma-delta , Transcription, GeneticABSTRACT
In the present study we investigated the effect of amino sugars on human natural killer (NK) activity against K562, a human myeloid leukemia cell line, and Molt-4, a human T lymphoma cell line. The presence of amino sugars such as D-mannosamine, D-galactosamine, and D-glucosamine [6-25 mM (in the case of D-mannosamine, 1.5-12.5 mM)] in a 4-hr chromium-51 (Cr) release assay significantly inhibited NK activity of large granular lymphocytes (LGL) without affecting effector cell viability or spontaneous release from target cells. Sugars with acetylated amino residues (N-acetyl-D-mannosamine, N-acetyl-D-galactosamine, and N-acetyl-D-glucosamine) showed much smaller NK inhibition. Among the amino sugars tested, D-mannosamine was the strongest suppressor. When either LGL or K562 cells were pretreated with amino sugars and used in the 4-hr 51Cr release assay, only the pretreatment of effector cells resulted in the reduction of NK activity. The binding capacity of LGL to K562 cells, determined by a conjugate assay, was not reduced by the amino sugars enough to explain the strong inhibition of NK activity by these amino sugars, although some inhibitory effect on the binding of LGL to K562 cells was observed in some cases. In contrast, the polarization of the effector cell cytoskeleton, one of the energy-dependent steps, was significantly impaired. The cellular ATP level of LGL was also significantly reduced and the reduction of cellular ATP correlated well with the degree of the inhibition of NK cytotoxicity. These results suggest that the suppression of NK activity by amino sugars is due to the reduction of the ATP-based energy supply of the effector cells and that amino sugars, especially D-mannosamine, should be recognized as potent suppressors of natural cell-mediated immunity.
Subject(s)
Amino Sugars/pharmacology , Killer Cells, Natural/drug effects , Adenosine Triphosphate/analysis , Cytoskeleton/physiology , Cytotoxicity, Immunologic , Dose-Response Relationship, Drug , Glucose/metabolism , Humans , Killer Cells, Natural/analysis , Killer Cells, Natural/immunology , Tumor Cells, CulturedABSTRACT
T and NK cell blood subpopulations were determined in 33 patients with B-CLL and in 14 patients with B-MLUS by two-color immunofluorescence. CLL patients had significantly higher total numbers of Leu-7+ and CD8+ cells and lower numbers of CD16+/Leu-7- cells as well as a higher Leu-7/CD16 ratio and a lower CD4/CD8 ratio than MLUS patients and control donors. Moreover, MLUS patients exhibited a significantly lower Leu-7/CD16 ratio as well as a higher frequency of CD16+/Leu-7- cells than healthy donors. These results suggest that B-CLL patients have higher numbers of circulating immature NK cells compared to B-MLUS, while B-MLUS patients have a larger proportion of NK cells with a high lytic capability as compared to both CLL and normal controls. The imbalance between CD4+ and CD8+ cells was prominent in CLL with a low CD4/CD8 ratio, but within the upper normal range in MLUS. Differences in immunoregulatory cell subpopulations between B-CLL and B-MLUS might therefore contribute to the different clinical behavior of these two disorders.
Subject(s)
B-Lymphocytes/immunology , Killer Cells, Natural/classification , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Lymphocytosis/blood , T-Lymphocytes/classification , Adult , Aged , Antigens, Differentiation , Clone Cells/immunology , Female , Humans , Killer Cells, Natural/analysis , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Leukocyte Count , Lymphocytosis/immunology , Male , Middle Aged , Phenotype , Staining and Labeling , T-Lymphocytes/analysisABSTRACT
Neural cell adhesion molecule (N-CAM) is a membrane glycoprotein expressed on neural and muscle tissues that is involved in homotypic adhesive interactions. We have demonstrated that N-CAM also is expressed on hematopoietic cells, and is recognized by the anti-Leu-19 mAb. Leu-19 is preferentially expressed on NK cells and T lymphocytes that mediate MHC-unrestricted cytotoxicity, but is also present on some myeloid leukemia cell lines. On NK cells, T cells, the KG1a.5 hematopoietic cell line, and a neuroblastoma cell line, Leu-19 is a approximately 140-kD polypeptide with N-linked carbohydrates and abundant sialic acid residues. Sequential immunoprecipitation and peptide mapping demonstrated that the Leu-19 and N-CAM molecules expressed on leukocyte and neuroblastoma cell lines are similar structures. These findings suggest that the Leu-19 antigen on leukocytes may be involved in cell adhesion, analogous to the function on N-CAM on neural cells.
Subject(s)
Antigens, Differentiation, T-Lymphocyte/isolation & purification , Antigens, Surface/isolation & purification , Membrane Glycoproteins/isolation & purification , Antigens, Differentiation, T-Lymphocyte/genetics , Antigens, Surface/genetics , CD56 Antigen , Cell Adhesion , Cell Adhesion Molecules , Cell Communication , Cell Line , Hematopoietic Stem Cells/analysis , Humans , Killer Cells, Natural/analysis , Leukemia, Myeloid/metabolism , Membrane Glycoproteins/genetics , N-Acetylneuraminic Acid , Nerve Tissue/analysis , Sialic Acids/analysis , T-Lymphocytes/analysis , Transcription, GeneticABSTRACT
Se estudió la actividad de las células NK en 19 enfermos con policitemia vera (13 mujeres y 6 hombres), de los cuales 11 se hallaban en estado de actividad de la enfermedad y 8 en remisión. Se encontró que existe una disminución significativa de esta función celular en 17 de los enfermos. Se analizan los resultados y se concluye que resulta de gran importancia la función de esta subpoblación celular como elemento regulador de la hemopoyesis en esta enfermedad
Subject(s)
Adult , Middle Aged , Humans , Male , Female , Killer Cells, Natural/analysis , Cytotoxicity, Immunologic , Polycythemia Vera/immunologyABSTRACT
Human renal allograft tissue was recovered at transplant nephrectomy from three patients with irreversible loss of graft function. This tissue was disaggregated and separated into two fractions on the basis of particle size. Fraction 1 contained glomeruli and developed a mixed outgrowth containing adherent epithelial and mesangial cells after a limited period of culture. Fraction 2 contained fragments of renal tubules and produced monolayers of tubular epithelial cells during culture. A population of lymphoid cells was observed to grow from the primary disaggregate into medium supplemented with recombinant human interleukin-2 (IL-2). After culture for 5 days these lymphoid cells were predominantly CD3-positive and carried both class II major histocompatibility antigens (MHC) and the CD25 IL-2 receptor. Culture of peripheral blood-derived mononuclear cells with IL-2 caused the generation of lymphokine-activated killer (LAK) cells; these cells were able to lyse both glomerular and tubular cells grown from nephrectomy tissue without showing MHC antigen restriction. The lymphoid cells grown from renal allograft tissue showed a similar lytic potential for both renal cells prepared from the same nephrectomy specimen and from third party renal tissue. It is possible that any LAK cells formed within a renal allograft by the action of IL-2 may contribute to the tissue destruction observed during graft rejection.
Subject(s)
Graft Rejection , Interleukin-2/pharmacology , Kidney Transplantation , Killer Cells, Natural/immunology , Cells, Cultured , Cytotoxicity Tests, Immunologic , Humans , Killer Cells, Natural/analysis , Killer Cells, Natural/drug effects , Receptors, Interleukin-2/analysis , Recombinant Proteins/pharmacology , Transplantation, HomologousABSTRACT
Natural killer (NK) cells in the human spleen represent a population of 25% of splenic lymphocytes. They are mainly located in the red pulp. In this compartment they resemble blood NK-cells in function and phenotype. Within the lymph follicles only a small subset is detected, expressing a particular phenotype.
Subject(s)
Killer Cells, Natural/analysis , Spleen/cytology , Antibodies, Monoclonal/immunology , Humans , Killer Cells, Natural/immunology , Spleen/immunologyABSTRACT
Freeze-fracture analysis has shown that treatment of cells with phorbol myristate acetate (PMA) results in a loss of intramembranous particles (IMP) associated with the external leaflet of their plasma membranes. It has also been demonstrated that phorbol esters markedly enhance the sensitivity of tumor targets to natural killer (NK) cells, although the mechanism underlying this phenomenon has remained unexplained. Since the ability of NK cells to recognize neoplasms appears to be inversely related to the concentration of sialic acid on the target cell surface, it seemed possible that phorbols affect membrane glycoproteins which have terminal carbohydrates bearing sialic acid residues. To investigate whether phorbol treatment could be responsible for the loss of sialic acid, four tumor cell lines were examined before and after exposure to PMA. A reduction in surface sialic acid was established by four different methods: 1) standard thiobarbituric acid analysis of cell hydrolysates, 2) metabolic labelling of cells with [3H]-mannosamine followed by treatment with neuraminidase, 3) chromatography of membrane extracts, and 4) freeze-fracture analysis of lectin-labelled intact cells. These observations suggest a mechanism whereby phorbols may facilitate NK-cell-mediated cytolysis. In addition, an entirely novel effect of these tumor-producing agents may have been uncovered.
Subject(s)
Cytotoxicity, Immunologic , Killer Cells, Natural/immunology , Neoplasms/immunology , Sialic Acids/analysis , Tetradecanoylphorbol Acetate/pharmacology , Cell Membrane/analysis , Freeze Fracturing , Humans , Killer Cells, Natural/analysis , N-Acetylneuraminic Acid , Neuraminidase/pharmacologyABSTRACT
Recent work from our laboratory has shown that NK cells rapidly release preformed factor(s) that stimulate monocyte oxidative metabolism and microbicidal activity. We have hypothesized that such factors could also activate macrophage (M phi) tumor lysis and might be stored in the cytoplasmic granules. Granules were isolated from the RNK large granular lymphocyte leukemias by nitrogen cavitation and Percoll fractionation of the cell homogenate. Utilizing CSF-1 differentiated murine bone marrow-derived M phi and P815 tumor target cells, a M phi-activating factor (MAF) was found. The MAF activity was identified in two peaks, the first was coincident with dense granule enzymes and was 60 times more concentrated per mg protein than a second peak in the cytosol fractions. Solubilization in 2 M NaCl was necessary to recover activity from both peaks. Granule NK-MAF required the simultaneous presence of LPS in order to induce tumoricidal activity. Kinetics of NK-MAF activation peaked after 12 h of exposure. The NK-MAF was short lived in the solubilized granules; however, its heat resistance allowed us to prepare enriched and stable preparations. Treatment of NK-MAF with pepsin but not trypsin completely abrogated its activity. The NK-MAF passed through an ultrafiltration membrane with a nominal cut-off of 10 kDa. This work indicates that NK cell granules contain a small heat-stable peptide capable of activating M phi tumoricidal activity.
Subject(s)
Cytoplasmic Granules/analysis , Killer Cells, Natural/analysis , Leukemia, Lymphoid/metabolism , Lymphokines/analysis , Animals , Bone Marrow , Cell Line , Cytoplasmic Granules/enzymology , Hot Temperature , Killer Cells, Natural/enzymology , Leukemia, Lymphoid/enzymology , Macrophage Activation/drug effects , Macrophage-Activating Factors , Mice , Mice, Inbred C3H , Peptide Hydrolases , Rats , Rats, Inbred F344ABSTRACT
Using a modified alkaline-phosphatase/antialkaline-phosphatase method for phenotyping fresh human leukemias, we could demonstrate peripheral blood and bone marrow-derived blast cells to specifically react with two monoclonal antibodies (MoAbs), H25 and H366, previously shown to recognize natural killer cells, activated T lymphocytes and a proportion of normal hematopoietic precursor cells. MoAbs H25 and H366 were found to identify the majority of leukemic cells in patients presenting with T-ALL, LGL leukemia, pre-B-ALL, CML, and AML, respectively.